AI-Powered Segmentation and Validation: A New Era for Lung Cancer Detection in Biomedical

It is still what we see as the number one cause of death world-wide; lung cancer. To improve patient chances of survival what we need is for an early and accurate diagnosis. Biomedical imaging which includes CT scans is what we have for the detection of lung cancer. Still, it is a great amount of time and judgment which goes into very closely looking at these images for signs of lung nodules which are an indicator of lung cancer. The rise of artificial intelligence as a player to really transform this is noteworthy. This study will contrast the various segmentation methods, identify the best method, and apply it to a hybrid model. Similar to this, segmented regions are used to apply the most effective feature extraction approaches in terms of mean square error and parameter execution time. Using the Feed Forward Back Propagation Neural Network and the SVM classifier (polynomial kernel property) to extract the valid key points from the segmented part classification, it will determine the greatest accuracy with the least amount of hybrid model complexity and execution time. In order to diagnose lung cancer, this article inquires the decision of AI algorithms on biomedical picture segmentation and validation. The method of detecting and separating regions of interest (ROIs) within an image automatically is called segmentation. Correctly extracting lung region from its neighboring tissues and further segmenting the potential nodules in the lung parenchyma are important initial steps to diagnose lung cancer. This limitation of manual analysis potential can be addressed by the AI-related segmentation algorithms, which often provide extreme performance accuracy together with efficiency. It is necessary to perform validation after segmentation in order to maintain the correctness of the ROIs obtained. In this paper, we explore the applicability of AI-based validation techniques to assess the robustness and fidelity in the segmentation process for various diseases, ultimately supporting better health management and promoting a healthy life. These strategies could involve training artificial intelligence (AI) models to differentiate between actual lung nodules and other anatomical content or artefacts that might be mistaken for a nodule. Cancer is considered worldwide as one of the major causes of death and morbidity. If current trends continue, up to 2030 an estimated 27 million more cancer cases are expected, according to the International Agency for Research on Cancer (IARC).